EdgarLookup

Biodexa Pharmaceuticals Plc — All Filings

653 total filings on record

Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.

Overview All Filings Financials Insiders
All 20-F 20-F/A 3 424B3 424B4 424B5 425 6-K 6-K/A 8-A12B 8-A12B/A CERTNAS CORRESP CT ORDER D DRS EFFECT F-1 F-1/A F-3 F-3/A F-4 F-4/A F-6 F-6 POS F-6/A FWP POS AM S-8 S-8 POS SC 13D SC 13G SC 13G/A SCHEDULE 13G SCHEDULE 13G/A SD UPLOAD
Form Description Accession Number Filed Period
20-F 0001214659-26-003921 Mar 27, 2026 Dec 31, 2025
6-K FORM 6-K 0001171843-26-001984 Mar 27, 2026
3 PRIMARY DOCUMENT 0001214659-26-003623 Mar 20, 2026 Mar 18, 2026
6-K 0001214659-26-003454 Mar 18, 2026
3 PRIMARY DOCUMENT 0001214659-26-003424 Mar 18, 2026
3 PRIMARY DOCUMENT 0001214659-26-003423 Mar 18, 2026
3 PRIMARY DOCUMENT 0001214659-26-003422 Mar 18, 2026
3 PRIMARY DOCUMENT 0001214659-26-003421 Mar 18, 2026
3 PRIMARY DOCUMENT 0001214659-26-003420 Mar 18, 2026
SCHEDULE 13G 0001172661-26-001269 Feb 17, 2026
424B3 PROSPECTUS SUPPLEMENT NO. 3 0001214659-26-001148 Feb 4, 2026
424B3 PROSPECTUS SUPPLEMENT NO. 3 0001214659-26-001147 Feb 4, 2026
424B3 PROSPECTUS SUPPLEMENT NO. 13 0001214659-26-001144 Feb 4, 2026
424B3 SUPPLEMENT NO 13 0001214659-26-001143 Feb 4, 2026
424B3 PROSPECTUS SUPPLEMENT NO. 2 0001214659-26-001140 Feb 4, 2026
424B3 PROSPECTUS SUPPLEMENT NO. 13 0001214659-26-001139 Feb 4, 2026
6-K 0001214659-26-001136 Feb 4, 2026
SCHEDULE 13G 0001535610-26-000008 Jan 20, 2026
424B3 PROSPECTUS SUPPLEMENT NO. 2 0001214659-26-000188 Jan 6, 2026
424B3 PROSPECTUS SUPPLEMENT NO. 12 0001214659-26-000191 Jan 6, 2026
424B3 PROSPECTUS SUPPLEMENT NO. 12 0001214659-26-000190 Jan 6, 2026
424B3 PROSPECTUS SUPPLEMENT NO. 1 0001214659-26-000193 Jan 6, 2026
424B3 PROSPECTUS SUPPLEMENT NO. 12 0001214659-26-000192 Jan 6, 2026
424B3 PROSPECTUS SUPPLEMENT NO. 2 0001214659-26-000189 Jan 6, 2026
6-K 0001214659-26-000187 Jan 6, 2026
6-K FORM 6-K 0001171843-26-000036 Jan 5, 2026
424B4 0001214659-25-018248 Dec 19, 2025
424B3 PROSPECTUS SUPPLEMENT NO. 11 0001214659-25-018206 Dec 18, 2025
424B3 PROSPECTUS SUPPLEMENT NO. 1 0001214659-25-018203 Dec 18, 2025
424B3 PROSPECTUS SUPPLEMENT NO. 1 0001214659-25-018202 Dec 18, 2025
424B3 PROSPECTUS SUPPLEMENT NO. 11 0001214659-25-018205 Dec 18, 2025
424B3 PROSPECTUS SUPPLEMENT NO. 11 0001214659-25-018204 Dec 18, 2025
6-K 0001214659-25-018196 Dec 18, 2025 Dec 17, 2025
EFFECT 9999999995-25-003807 Dec 17, 2025
F-1/A AMENDMENT NO. 2 0001214659-25-017944 Dec 11, 2025
F-1/A AMENDMENT NO. 1 0001214659-25-017719 Dec 8, 2025
424B3 0001214659-25-017136 Nov 24, 2025
424B3 0001214659-25-017135 Nov 24, 2025
EFFECT 9999999995-25-003343 Nov 21, 2025
EFFECT 9999999995-25-003337 Nov 21, 2025
POS AM AMENDMENT NO. 2 0001214659-25-016826 Nov 17, 2025
F-1 0001214659-25-016821 Nov 17, 2025
POS AM AMENDMENT NO. 2 0001214659-25-016809 Nov 17, 2025
SCHEDULE 13G/A 0000902664-25-005038 Nov 14, 2025
424B3 PROSPECTUS SUPPLEMENT 10 0001214659-25-015745 Nov 3, 2025
424B3 PROSPECTUS SUPPLEMENT 10 0001214659-25-015744 Nov 3, 2025
424B3 PROSPECTUS SUPPLEMENT 10 0001214659-25-015743 Nov 3, 2025
6-K 0001214659-25-015739 Nov 3, 2025
EFFECT 9999999995-25-003258 Sep 30, 2025
CORRESP 0001214659-25-014284 Sep 29, 2025